Barman-AksÓ§zen noted that she became the first patient to present directly to the European Medicines Agency (EMA) committee ...
We fully endorse the Editorial1 on the negative opinion of the European Medicines Agency of the use of lecanemab for the treatment of early Alzheimer's disease. Investigators from the European ...
Kebilidi is the first gene therapy approved by the FDA for administration directly into the brain, given via a cannula during ...
In a similar manner, member states must now pool their resources to address their shared geoeconomic concerns. To achieve ...
Some pet owners want a recall of a new arthritis drug for cats after their animals died, some in horrific ways, just days ...
Instead, they’re left wondering how their pets ended up hurt or dead, after getting a shot that was supposed to give them new ...
PTC Therapeutics' gene therapy is already approved in the European Union, Great Britain, and Israel. The drugmaker will also ...
NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (Germany: J90) (" NurExone " or the " Company "), a biopharmaceutical company developing exosome-based regenerative therapies, is pleased to announce ...
Product development highlights Alvotech announced that the European Medicines Agency (EMA) accepted a Marketing Authorization ...
EU antitrust regulators have asked pharma rivals and customers for feedback in four business areas in light of Novo Holdings' ...
Intercept’s US president Vivek Devaraj said the pharma company still believes in the evidence supporting the liver disease ...
We recently published a list of 10 Top Performing European Stocks Heading into 2025. In this article, we are going to take a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback